Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Stibbe

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
ASAIO Transactions|January 1, 1990
Low molecular weight heparin versus standard heparin. A long-term study in hemodialysis and hemofiltration patientsJ Schrader, W Stibbe, M Kandt, et al.
Deutsche Medizinische Wochenschrift (1946)|January 29, 1982
[Preparation and testing of a hepatitis B vaccine (author's transl)]R Thomssen, W Gerlich, U Böttcher, et al.
Kidney International|April 1, 1988
Comparison of low molecular weight heparin to standard heparin in hemodialysis/hemofiltrationJ Schrader, W Stibbe, V W Armstrong, et al.
Developments in Biological Standardization|January 1, 1983
Safety and potency aspects in the preparation of an experimental HBsAg vaccineR Thomssen, W H Gerlich, U Böttcher, et al.
Kidney International|November 1, 1985
Low molecular weight heparin in hemodialysis and hemofiltration patientsJ Schrader, R Valentin, H J Tönnis, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
ASAIO Transactions|January 1, 1990
Low molecular weight heparin versus standard heparin. A long-term study in hemodialysis and hemofiltration patientsJ Schrader, W Stibbe, M Kandt, et al.
Deutsche Medizinische Wochenschrift (1946)|January 29, 1982
[Preparation and testing of a hepatitis B vaccine (author's transl)]R Thomssen, W Gerlich, U Böttcher, et al.
Kidney International|April 1, 1988
Comparison of low molecular weight heparin to standard heparin in hemodialysis/hemofiltrationJ Schrader, W Stibbe, V W Armstrong, et al.
Developments in Biological Standardization|January 1, 1983
Safety and potency aspects in the preparation of an experimental HBsAg vaccineR Thomssen, W H Gerlich, U Böttcher, et al.
Kidney International|November 1, 1985
Low molecular weight heparin in hemodialysis and hemofiltration patientsJ Schrader, R Valentin, H J Tönnis, et al.
Pageof 2